ReCode Therapeutics Competitors and Similar CompaniesClear all
ReCode Therapeutics's competitors and similar companies include BillionToOne, Synspira and Breath Therapeutics.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  Synspira Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases. |  Breath Therapeutics Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2017 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Menlo Park, US HQ | Locations Menlo Park, US HQ | Locations Framingham, US HQ | Locations Dieburg, DE HQ München, DE Cambridge, US |
Employees | Employees 1062% decrease | Employees 620 | Employees 6 | Employees N/A |
Funding | ||||
Latest funding round | Latest funding round $ 80m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 3m (over 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 82m | Total funding raised $ 87.5m | Total funding raised $ 11.2m | Total funding raised $ 46m |
For sources of this data, please see the company profile
View Company Profiles
BillionToOne
HQ
Menlo Park, US
Employees
620
BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.
View companySynspira
HQ
Framingham, US
Employees
6
Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases.
View companyBreath Therapeutics
HQ
Dieburg, DE
Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases.
View company